GPC1 and endometrial carcinoma: The results showed that the expression alterations of PFKM, NUP85, PDHA1, CDK1, CLDN9, CENPA, GPI, NUP155, and GPC1 in endometrial carcinoma samples were 5, 7, 4, 3, 5, 5, 7, 6, and 3%, respectively.